Cargando…

Estimation of minimally important differences in the EQ-5D and SF-6D indices and their utility in stroke

BACKGROUND: The aim of the present study was to estimate minimally important differences (MIDs) in EQ-5D and SF-6D indices and to explore the responsiveness of EQ-5D and SF-6D indices in stroke. METHODS: We used observational longitudinal survey data of EQ-5D and SF-36 that were administered to stro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Sang-Kyu, Kim, Seon-Ha, Jo, Min-Woo, Lee, Sang-il
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359514/ https://www.ncbi.nlm.nih.gov/pubmed/25889191 http://dx.doi.org/10.1186/s12955-015-0227-3

Ejemplares similares

Deriving a mapping algorithm for converting SF-36 scores to EQ-5D utility score in a Korean population
por: Kim, Seon-Ha, et al.
Publicado: (2014)

Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer
por: Pickard, A Simon, et al.
Publicado: (2007)

Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer
por: Pickard, A Simon, et al.
Publicado: (2010)

A cross sectional survey on health-related quality of life of elementary school students using the Korean version of the EQ-5D-Y
por: Kim, Sang-Kyu, et al.
Publicado: (2017)

Validity of EQ-5D utility index and minimal clinically important difference estimation among patients with chronic obstructive pulmonary disease
por: Bae, Eunmi, et al.
Publicado: (2020)

Exploring the validity of estimating EQ-5D and SF-6D utility values from the health assessment questionnaire in patients with inflammatory arthritis
por: Harrison, Mark J, et al.
Publicado: (2010)

Comparison between EQ-5D and SF-6D Utility in Rural Residents of Jiangsu Province, China
por: Jin, Hui, et al.
Publicado: (2012)

Mapping analysis to estimate EQ-5D utility values using the COPD assessment test in Korea
por: Lim, Jaeok, et al.
Publicado: (2019)

Comparison of the SF-6D and the EQ-5D in patients with coronary heart disease
por: van Stel, Henk F, et al.
Publicado: (2006)

Comparison of SF-6D and EQ-5D Scores in Patients With Breast Cancer
por: Yousefi, Mahmood, et al.
Publicado: (2016)

Mapping EORTC QLQ-C30 onto EQ-5D for the assessment of cancer patients
por: Kim, Seon Ha, et al.
Publicado: (2012)

Validity and reliability of EQ-5D-3L for breast cancer patients in Korea
por: Kim, Seon-Ha, et al.
Publicado: (2015)

Japanese population norms for preference-based measures: EQ-5D-3L, EQ-5D-5L, and SF-6D
por: Shiroiwa, Takeru, et al.
Publicado: (2015)

The comparative responsiveness of the EQ-5D and SF-6D to change in patients with inflammatory arthritis
por: Harrison, M. J., et al.
Publicado: (2009)

Mapping the FACT-G cancer-specific quality of life instrument to the EQ-5D and SF-6D
por: Teckle, Paulos, et al.
Publicado: (2013)

What is the relationship between the minimally important difference and health state utility values? The case of the SF-6D
por: Walters, Stephen J, et al.
Publicado: (2003)

An empirical evaluation of the SF-12, SF-6D, EQ-5D and Michigan Hand Outcome Questionnaire in patients with rheumatoid arthritis of the hand
por: Dritsaki, Melina, et al.
Publicado: (2017)

Mapping the PHQ-8 to EQ-5D, HUI3 and SF6D in patients with depression
por: Abdin, Edimansyah, et al.
Publicado: (2021)

Mapping the Positive and Negative Syndrome Scale scores to EQ-5D-5L and SF-6D utility scores in patients with schizophrenia
por: Abdin, Edimansyah, et al.
Publicado: (2018)

Level of agreement between patient-reported EQ-5D responses and EQ-5D responses mapped from the SF-12 in an injury population
por: Gabbe, Belinda J, et al.
Publicado: (2015)

A Comparison of EQ-5D-3L, EQ-5D-5L, and SF-6D Utilities of Patients with Musculoskeletal Disorders of Different Severity: A Health-Related Quality of Life Approach
por: Kontodimopoulos, Nikolaos, et al.
Publicado: (2022)

Estimating the burden of disease in chronic pain with and without neuropathic characteristics: Does the choice between the EQ-5D and SF-6D matter?
por: Torrance, Nicola, et al.
Publicado: (2014)

Mapping SF-36 onto the EQ-5D index: how reliable is the relationship?
por: Rowen, Donna, et al.
Publicado: (2009)

Comparison of the EQ-5D 3L and the SF-6D (SF-36) contemporaneous utility scores in patients with chronic kidney disease in Sri Lanka: a cross-sectional survey
por: Kularatna, Sanjeewa, et al.
Publicado: (2019)

Comparing the performance of the EQ-5D and SF-6D when measuring the benefits of alleviating knee pain
por: Barton, Garry R, et al.
Publicado: (2009)

Estimating EQ-5D and OAB-5D health state utilities for patients with overactive bladder
por: Desroziers, Katia, et al.
Publicado: (2013)

Discriminative validity of the EQ-5D-5 L and SF-12 in older adults with arthritis
por: Tawiah, Andrews K., et al.
Publicado: (2019)

The minimal important change for the EQ VAS based on the SF-36 health transition item: observations from 25772 spine surgery procedures
por: Joelson, Anders, et al.
Publicado: (2022)

A Comparison between the EQ-5D and the SF-6D in Patients with Chronic Obstructive Pulmonary Disease (COPD)
por: Chen, Jing, et al.
Publicado: (2014)

Factors Associated with Health-Related Quality of Life in Korean Patients with Chronic Hepatitis C Infection Using the SF-36 and EQ-5D
por: Jang, Eun Sun, et al.
Publicado: (2018)

The impact of different rheumatic diseases on health-related quality of life: a comparison with a selected sample of healthy individuals using SF-36 questionnaire, EQ-5D and SF-6D utility values
por: Fausto, Salaffi, et al.
Publicado: (2018)

Health utility measurement for people living with HIV/AIDS under combined antiretroviral therapy: A comparison of EQ-5D-5L and SF-6D
por: Wang, Xiaowen, et al.
Publicado: (2022)

Estimation of minimally important difference of the EQ-5D-5L utility scores among patients with either hypertension or diabetes or both: a cross-sectional study in Hong Kong
por: XU, Richard Huan, et al.
Publicado: (2020)

The Importance of Accounting for Parameter Uncertainty in SF-6D Value Sets and Its Impact on Studies that Use the SF-6D to Measure Health Utility
por: Kharroubi, Samer A., et al.
Publicado: (2020)

Comparing responsiveness of the EQ-5D-5L, EQ-5D-3L and EQ VAS in stroke patients
por: Golicki, Dominik, et al.
Publicado: (2014)

Estimating the disutility of relapse in relapsing–remitting and secondary progressive multiple sclerosis using the EQ-5D-5L, AQoL-8D, EQ-5D-5L-psychosocial, and SF-6D: implications for health economic evaluation models
por: Ahmad, Hasnat, et al.
Publicado: (2023)

The construct validity and responsiveness of the EQ-5D, SF-6D and Diabetes Health Profile-18 in type 2 diabetes
por: Mulhern, Brendan, et al.
Publicado: (2014)

Comparison of the psychometric properties of the EQ-5D-3L and SF-6D in the general population of Chengdu city in China
por: Zhao, Longchao, et al.
Publicado: (2019)

Mapping analyses to estimate EQ-5D utilities and responses based on Oxford Knee Score
por: Dakin, Helen, et al.
Publicado: (2012)

A comparison of the sensitivity of EQ-5D, SF-6D and TTO utility values to changes in vision and perceived visual function in patients with primary open-angle glaucoma
por: Bozzani, Fiammetta Maria, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_5b3llivcs031pio6o34or5u9ct